Metraipolis › archive › dc_390bca83c07e

Enhanced Anti-Lung Cancer Efficacy of Neo-BCV Combined with Cisplatin: Immune Activation and Tumor Microenvironment Remodeling — Europe PMC PMID:42188807

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188807
DOI
10.3390/vaccines14050436
License (as archived)
solo-consultazione
Archived
2026-11-02T10:54:07.031Z
SHA-256 of the archived text
62454f9dd947ca2e7c2ec8af16e29e9d3d9c5561aff797f44379ef589a9a32f1
Stable URL of this page
https://metraipolis.com/documento/dc_390bca83c07e

How to cite

Enhanced Anti-Lung Cancer Efficacy of Neo-BCV Combined with Cisplatin: Immune Activation and Tumor Microenvironment Remodeling — Europe PMC PMID:42188807 — Europe PMC (en), https://europepmc.org/article/MED/42188807 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_390bca83c07e (Metraipolis archive dc_390bca83c07e, sha256 62454f9dd947ca2e7c2ec8af16e29e9d3d9c5561aff797f44379ef589a9a32f1)
BibTeX
@misc{dc390bca83c07e,
  title = {Enhanced Anti-Lung Cancer Efficacy of Neo-BCV Combined with Cisplatin: Immune Activation and Tumor Microenvironment Remodeling — Europe PMC PMID:42188807},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188807},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_390bca83c07e; sha256 62454f9dd947ca2e7c2ec8af16e29e9d3d9c5561aff797f44379ef589a9a32f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188807. Agents can read the archived copy with the MCP tool read_document.